Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study-Reference-Cited by-同舟云学术

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

Published:2008-11 Issue:6 Volume:23 Page:357-363
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Kornstein Susan G.,Kocsis James H.,Ahmed Saeeduddin,Thase Michael,Friedman Edward S.,Dunlop Boadie W.,Yan Bing,Pedersen Ron,Ninan Philip T.,Li Thomas,Keller Martin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference13 articles.

1. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

2. The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study

3. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

4. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence;Neuropsychopharmacology;2023-07-25

2. When to stop medication in unipolar depression: A systematic review and a meta-analysis of randomized controlled trials;Journal of Affective Disorders;2023-03

3. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022

4. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022

5. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults;Cochrane Database of Systematic Reviews;2021-04-22